These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 14415)

  • 1. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosslinking of monomeric fibrin by factor XIIIa.
    Dardik BN; Shainoff JR
    Thromb Haemost; 1979 Oct; 42(3):864-72. PubMed ID: 505402
    [No Abstract]   [Full Text] [Related]  

  • 6. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of a fibrin-promoting enzyme from the venom of Agkistrodon contortrix contortrix on rat fibrinogen and plasma.
    Dyr JE; Suttnar J; Simák J; Fortová H; Kornalík F
    Toxicon; 1990; 28(11):1364-7. PubMed ID: 2087698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.
    Vu TT; Stafford AR; Leslie BA; Kim PY; Fredenburgh JC; Weitz JI
    J Biol Chem; 2013 Jun; 288(23):16862-16871. PubMed ID: 23612970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides.
    Weisel JW
    Biophys J; 1986 Dec; 50(6):1079-93. PubMed ID: 3801570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ascorbate and histidine in fibrinogen protection against changes following exposure to a sterilizing dose of gamma-irradiation.
    Zbikowska HM; Nowak P; Wachowicz B
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):669-76. PubMed ID: 17890955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking.
    Weiss E; Yamaguchi Y; Falabella A; Crane S; Tokuda Y; Falanga V
    J Cell Physiol; 1998 Jan; 174(1):58-65. PubMed ID: 9397156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.